Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
Norwegian video conferencing company Pexip has been hailed by equity capital markets bankers as an ideal IPO for the times amid a surge in remote working due to the Covid-19 global pandemic.
-
The possibility of oil prices returning to negative territory snapped back into focus on Monday, as the USO ETF, which holds a large proportion of West Texas Intermediate front month futures, decided to roll its positions this week.
-
More than £2.3bn ($2.86bn) of UK securitizations are coming up for call, as a majority of the year’s redemption schedule is packed into the current quarter. Investors expect banks to call as normal, but see non-bank deals as likely to miss their calls and extend.
-
Last week, IDB Invest raised $1bn with its largest deal ever, a $1bn two year fixed rate bond. Although the proceeds of the bond will not be segregated from its regular funding, the issuer is adding a “Covid-19 lens” to the framework used to assess its development effectiveness.
-
Investment banks are working with issuers preparing rights issues for balance sheet repair, as governments across Europe prepare to ease Covid-19 lockdowns.
-
Italy’s credit rating is dividing analysts. Some believe that it should have been downgraded by S&P on April 24 because of the country's ballooning debt burden, while others felt that the European Central Bank can keep the refinancing risk at bay.